Hydroxychloroquine in Type 2 Diabetes During Pregnancy
Hydroxychloroquine as an Adjunct Therapy in the Management of Type 2 Diabetes in Pregnancy: A Randomised Controlled Trial
National University of Malaysia
56 participants
Mar 24, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main questions it aims to answer are: * Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment
Eligibility
Inclusion Criteria2
- Singleton
- Pregnant women with a confirmed diagnosis of type 2 Diabetes Mellitus
Exclusion Criteria6
- autoimmune disease such as Systemic Lupus Erythematosus or rheumatic disease
- chronic kidney disease
- fetal anomaly
- women on steroid therapy
- diabetic retinopathy
- known thalassaemia or thalassaemia carrier
Interventions
200mg daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06319560